Recombinant IL9 (Enokizumab Biosimilar) antibody
The Human Monoclonal anti-IL9 (Enokizumab Biosimilar) antibody (ABIN7675783) specifically detects IL9 (Enokizumab Biosimilar) in ELISA, FACS, BLI, Func and SPR.
The antibody is reactive with Human samples.
Catalog No. ABIN7675783
-15% Promotion 2026
$294.23
save $51.92 (-15 %)
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 10 to 11 Business Days
Quick Overview for Recombinant IL9 (Enokizumab Biosimilar) antibody (ABIN7675783)
Target
IL9 (Enokizumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Conjugate
This IL9 (Enokizumab Biosimilar) antibody is un-conjugated
Application
ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)
-
-
Expression System
- CHO Cells
-
Purpose
- Anti-IL-9 Reference Antibody (enokizumab)
-
Characteristics
- Anti-IL-9 Reference Antibody (enokizumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
-
Purity
- >95 %
-
Isotype
- IgG1
-
-
anti-IL9 (Enokizumab Biosimilar) antibody
Research Grade Reactivity: Human ELISA, FACS Host: Humanized Monoclonal unconjugated
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- 1 mg/mL
-
Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
Storage
- 4 °C,-80 °C
-
Storage Comment
- +4°C,-80°C
-
-
- IL9 (Enokizumab Biosimilar)
-
Alternative Name
- IL-9 (Enokizumab Biosimilar)
-
Target Type
- Biosimilar
-
Molecular Weight
- 145.5 kDa
-
UniProt
- P15248
Target
-
You are here:
